Skip to main content
← Companies
URGN

UroGen Pharma Ltd.

Data as of Sep 17, 2026
URGN
CIK 1668243Pharmaceutical Preparations

Lobbying

$210,000 in reported federal lobbying spend across 7 quarterly filings, most recently Jul 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.

Latest filings, Apr 2025 onward

FiledRegistrant and subjectAmount
Jul 20, 2026
BGR GOVERNMENT AFFAIRS for UROGEN PHARMA INC.
Unspecified
$30,000
Apr 20, 2026
BGR GOVERNMENT AFFAIRS for UROGEN PHARMA INC.
Unspecified
$30,000
Jan 20, 2026
BGR GOVERNMENT AFFAIRS for UROGEN PHARMA INC.
Unspecified
$30,000
Oct 20, 2025
BGR GOVERNMENT AFFAIRS for UROGEN PHARMA INC.
Unspecified
$30,000
Jul 21, 2025
BGR GOVERNMENT AFFAIRS for UROGEN PHARMA INC.
Unspecified
$30,000
Apr 21, 2025
BGR GOVERNMENT AFFAIRS for UROGEN PHARMA INC.
Unspecified
$30,000

Data: Quiver Quantitative, FEC, Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to UroGen Pharma Ltd. through its SEC registration (CIK 1668243) and tickers URGN.

As of: lobbying filings through Jul 20, 2026; contract actions through Feb 11, 2026. Snapshot rebuilt Sep 17, 2026.

Holdings values are estimates from disclosed ranges. Donation coverage for a cycle begins with the first month loaded, so earlier months may still be missing.